6 April, 2011
A new Avandia study has reached a familiar conclusion: Avandia poses a higher risk of heart attack, congestive heart failure (CHF) and death compared to its rival diabetes drug, Actos. The new research confirms the findings of earlier Avandia heart risks studies. Continue reading Avandia heart attack, CHF and stroke risks higher, new study confirms
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Safety | Avandia Settlements | Avandia Side Effects